You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › November › 03
Pfizer
8 months ago
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid ⊖⊖
Suit alleges merger would violate competition laws in market for weight-loss drugs
page 1 of 1